openPR Logo
Press release

United States Allergy Immunotherapies Market 2025 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities

10-10-2025 02:30 PM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Allergy Immunotherapies Market

Allergy Immunotherapies Market

Market Size and Growth

The "Global Allergy Immunotherapies Market" is predicted to reach at a high CAGR of 10.4% during the forecast period (2022-2029)

Key Development:

United States: Recent Industry Developments

✅ In September 2025, Sanofi expanded its allergy immunotherapy portfolio by acquiring Ayvakit and early-stage immunology assets for USD 9.1 billion, enhancing its position in severe allergic conditions.

✅ In June 2025, BioVaxys Technology Corp. launched a private placement to raise USD 1.2-1.6 million, aiming to advance its food allergy immunotherapy pipeline.

✅ In June 2025, Curex introduced a telehealth platform offering at-home allergy testing and sublingual immunotherapy, expanding access to personalized allergy care.

Japan: Recent Industry Developments

✅ In July 2025, Shionogi & Co., Ltd. transitioned promotional activities for Actair®, a sublingual immunotherapy tablet for house dust mite-induced allergic rhinitis, to CEOLIA Pharma Co. Ltd.

✅ In February 2025, Torii Pharmaceutical Co., Ltd. announced the expected launch of TO-208, an immunotherapy for mollusc-um contagiosum, marking a significant step in expanding its allergy treatment portfolio.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/allergy-immunotherapies-market?sb

Allergy immunotherapies are treatments designed to reduce allergic reactions by gradually desensitizing the immune system to specific allergens. They include subcutaneous (SCIT) and sublingual (SLIT) therapies, helping manage conditions like allergic rhinitis, asthma, and insect venom allergies while providing long-term symptom relief.

Key Players:

=> Merck KGaA, Stallergenes Greer plc , Allergy Therapeutics , Mylan N.V., ASIT Biotech, DBV Technologies SA, LETIPharma.

Growth Forecast Projected:

The Global Allergy Immunotherapies Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Allergy Immunotherapies Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=allergy-immunotherapies-market

Key Segments:

➥ By Treatment Type: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT)
➥ By Allergy Type: Allergic Rhinitis, Allergic Asthma, Others
➥ By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Regional Analysis for Allergy Immunotherapies Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Allergy Immunotherapies producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Allergy Immunotherapies revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/allergy-immunotherapies-market?sb

FAQ

Q: What is the growth rate of the Allergy Immunotherapies Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 10.4% during the forecast period from 2022 to 2029.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Allergy Immunotherapies Market 2025 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities here

News-ID: 4218194 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Cancer CDK Inhibitors Market 2025 | Growth Drivers, Key Players & Investment Opportunities
United States Cancer CDK Inhibitors Market 2025 | Growth Drivers, Key Players & …
Market Size and Growth Global Cancer CDK Inhibitors Market reached US$ 9.3 billion in 2023 and is expected to reach US$ 13.8 billion by 2031, growing at a CAGR of 5.2% during the forecast period 2024-2031. Key Development: United States: Recent Industry Developments ✅ In June 2025, Gilead Sciences and Kymera Therapeutics entered into an exclusive option and license agreement to develop novel oral molecular glue CDK2 degraders. This collaboration aims to accelerate the
United States Urinalysis Testing Products Market 2025 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities
United States Urinalysis Testing Products Market 2025 | Growth Drivers, Trends & …
Market Size and Growth Urinalysis Testing Products market is estimated to reach at a high CAGR of 7.3 % during the forecast period (2023-2030). Key Development: United States: Recent Industry Developments ✅ In April 2025, H.U. Group Holdings, Inc. and its subsidiary Fujirebio Holdings, Inc. received a $4.5 million grant from the Global Health Innovative Technology (GHIT) Fund to develop an ultrasensitive point-of-care urine test for tuberculosis. Japan: Recent Industry Developments ✅ In June 2025,
Global Green Hydrogen Market Projected to Grow at 20.9% CAGR Through 2031, Driven by Clean Energy Transition and Policy Support
Global Green Hydrogen Market Projected to Grow at 20.9% CAGR Through 2031, Drive …
The Global Green Hydrogen Market is expected to grow at a CAGR of 20.9% during the forecast period (2024-2031), according to DataM Intelligence. United States: Recent Industry Developments ✅ In September 2025, The Department of Energy announced $8 billion in funding for regional green hydrogen hubs under the Infrastructure Investment and Jobs Act. ✅ In August 2025, Plug Power commissioned the largest green hydrogen production facility in North America
United States Castration Resistant Prostate Cancer Treatment Market 2025 | Growth Drivers, Key Players & Investment Opportunities
United States Castration Resistant Prostate Cancer Treatment Market 2025 | Growt …
Market Size and Growth The Global Castration Resistant Prostate Cancer Treatment Market is expected to grow at a CAGR of 9% during the forecasting period (2024-2031). Key Development: United States: Recent Industry Developments ✅ In August 2025, the FDA approved the initiation of a Phase 1 trial for KTX-2001, an NSD2 inhibitor, in combination with darolutamide for metastatic castration-resistant prostate cancer patients who have progressed after prior androgen receptor pathway inhibitor treatment. ✅ In August

All 5 Releases


More Releases for Allergy

Allergy Shots Market | ALK Abello, Aimmune Therapeutics, Allergy Therapeutics, A …
The global allergy shots market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the allergy shots market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the
Allergy Shots Market: Rising Demand and Advancements in Allergy Treatment
Market Overview: The Allergy Shots market refers to the production, distribution, and utilization of immunotherapy treatments known as allergy shots or allergen immunotherapy. Allergy shots are a form of treatment for allergies, particularly for allergic rhinitis (hay fever), allergic asthma, and insect sting allergies. They involve the administration of gradually increasing doses of allergens, such as pollen, dust mites, pet dander, or insect venom, to desensitize the immune system and
Allergy Treatment Market Increasing Demand By Allergy Type: Eye Allergy, Rhiniti …
Acumen Research and Consulting has announced the addition of the "Allergy Treatment Market” report to their offering. The Allergy Treatment Market Report 2018 is an in depth study analyzing the current state of the Allergy Treatment Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Allergy Treatment Market provides analysis of China market covering the industry trends, recent
Allergy Immunotherapy Market to Witness Huge Growth by Key Players: Allergy Ther …
According to a recent research study "Allergy Immunotherapy Market, by immunotherapy Type (SCIT, SLIT), By Type of Allergy (Asthma, Food Allergy, Allergic Rhinitis and Others) opportunities and forecast 2020-2026" published by Data Library Research, the Allergy Immunotherapy Market Studies many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key
Allergy Treatment Market Report 2018: Segmentation by Allergy Type (Food Allergy …
Global Allergy Treatment market research report provides company profile for Meda Pharmaceuticals Inc., Allergy Therapeutics, Sunovion Pharmaceuticals Inc., Allergon AB, Allergan, HAL Allergy Group, Teva Pharmaceutical and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Allergy Treatment Global Market 2018: Key Players – ALK, Stallergenes Greer, A …
Allergy Treatment Industry Description Wiseguyreports.Com Adds “Allergy Treatment -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database This report studies the global Allergy Treatment market, analyzes and researches the Allergy Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like  ALK  Stallergenes Greer  Allergy Therapeutics  HAL Allergy Group  Circassia  GlaxoSmithKline plc  Sunovion Pharmaceuticals  Teva Pharmaceutical Industries  Allergan plc  Allergon